|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
|
|---|---|---|---|---|
| Assets | ||||
| Current asset | ||||
| Cash | ||||
| Total current asset | ||||
| Cash and marketable securities held in trust | ||||
| Deferred offering costs | ||||
| Total Assets | ||||
| Liabilities and Shareholders’ (Deficit)/Equity | ||||
| Promissory note - related party | ||||
| Payable to a third party | ||||
| Total current liabilities | ||||
| Total Liabilities | ||||
| Ordinary shares subject to redemption, 5,750,000 shares (at redemption price of $9.29 per share) | ||||
| Shareholders’ (deficit)/equity | ||||
| Ordinary shares, value | ||||
| Additional paid-in capital | ||||
| Accumulated deficit | ||||
| Total shareholders’ (deficit)/equity | ||||
| Total Liabilities and Shareholders’ (Deficit)/Equity |
Loading...
